Showing 8571-8580 of 10139 results for "".
- Almirall S.A. to Aquire Aqua Pharmaceuticalshttps://practicaldermatology.com/news/20131217-almirall_sa_to_aquire_aqua_pharmaceuticals/2459392/
- Mela Sciences Reports Positive Feedback on MelaFind during Clinical Advisory Meetinghttps://practicaldermatology.com/news/20131210-mela_sciences_reports_positive_feedback_on_melafind_during_clinical_advisory_meeting/2459396/
- ASLMS Announces Dr. Horace Furumoto Award Recipientshttps://practicaldermatology.com/news/20131126-laser_society_announces_dr_horace_furumoto_award_recipients/2459402/Michael H. Slayton, Ph.D. and Ishan Barman, Ph.D. will receive the Horace Furumoto Innovations Professional Development Awards at the upcoming meeting of the American Society for Laser Medicine & Surgery, Inc. (ASLMS), which will be held in April 2014, in Phoenix, AZ. Dr. Thomas Rohrer, Chair of the
- NIH Awards Icahn School of Medicine at Mount Sinai $2.7 Million for Eczema Researchhttps://practicaldermatology.com/news/20131126-nih_awards_icahn_school_of_medicine_at_mount_sinai_27_million_for_eczema_research/2459404/
- Myriad Genetics Launches myPath Melanoma Diagnostic Testhttps://practicaldermatology.com/news/20131114-myriad_genetics_launches_mypath_melanoma_diagnostic_test/2459416/
- Merz Pharma Group Acquires Anteis S.A.https://practicaldermatology.com/news/20131112-merz_pharma_group_acquires_anteis_sa/2459418/
- Rigel Provides Pipeline Updatehttps://practicaldermatology.com/news/20131024-rigel_provides_pipeline_update/2459429/Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced updates on two of the Company's pipeline products: R333, a topical dermatological JAK/SYK inhibitor, and fostamatinib, an oral SYK inhibitor.
- ASDS Elects New Officers, Board Membershttps://practicaldermatology.com/news/20131016-asds_elects_new_officers_board_members/2459435/The American Society for Dermatologic Surgery (ASDS) announces the election of Naomi Lawrence, M.D., as Vice President as well as a new Secretary and three new board members during its Annual Meeting in Chicago. The Society's newly elected officials will join President Mitchel P. Goldman, M.D., and
- Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integrationhttps://practicaldermatology.com/news/20130926-modernizing_medicine_and_miraca_life_sciences_partner_to_create_enhanced_emr_and_pathology_lab_integration/2459448/
- ResurFX for M22 Platform from Lumenis Receives FDA Clearancehttps://practicaldermatology.com/news/20130917-resurfx_for_m22_platform_from_lumenis_receives_fda_clearance/2459459/The FDA recently granted 510(k) clearance for ResurFX, a new fractional non-ablative laser module from Lumenis. ResurFX is the latest application module for the company's M22 platform, expanding its capabilities to perform true fractional non-ablative skin resurfacing.